Delivery Order SPE2DB22D2007-SPE2DB25FJ5AR
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $51,681.12 to AmerisourceBergen Drug Corp for the supply of Revlimid 10 mg capsules (28-count units) on July 30, 2025, with an ultimate completion date of August 20, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a discrete procurement action issued under...
- The Defense Logistics Agency awarded a $51,089.97 delivery order to AmerisourceBergen Drug Corp for Revlimid 10 mg capsules (28-count) on September 9, 2025, with performance completion targeted for September 30, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen is a major pharmaceutical distributor and critical federal medical...
- The Defense Logistics Agency awarded a $267,465.18 delivery order to AmerisourceBergen Drug Corp for REVLIMID 10 mg capsules (100-count units) under a firm fixed-price contract. The order, issued on May 29, 2025, is scheduled for completion by June 20, 2025, and represents a competitive award with no set-aside designation. AmerisourceBergen's place of performance is located in Conshohocken, Pennsylvania, the company's corporate headquarters. This delivery order is issued under...
- The Defense Logistics Agency has awarded a delivery order valued at $51,879.46 to AmerisourceBergen Drug Corp for the supply of Revlimid 5 mg capsules (100-count units). This competitively awarded, firm fixed-price delivery order carries an ultimate completion date of September 26, 2025, and represents a non-set-aside procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location in...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $12,329.15 for Revlimid 5 mg capsules (28-count) on October 31, 2025, with an ultimate completion date of November 24, 2025. This firm fixed-price, competitively awarded contract includes no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under the company's existing Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a $12,329.16 delivery order to AmerisourceBergen Drug Corp for 28 capsules of Revlimid 5 mg on July 28, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The order was competitively awarded with no set-aside designation and...
- The Defense Logistics Agency awarded a delivery order valued at $25,840.56 to AmerisourceBergen Drug Corp for the supply of Revlimid 10 mg capsules (28-count units) under a firm fixed price contract. The award, issued on August 6, 2025, with an ultimate completion date of August 27, 2025, represents a non-set-aside, competitively awarded procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location and will fulfill...
- The Defense Logistics Agency awarded a $27,425.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Revlimid 2.5 mg capsules (28-count units), with an ultimate completion date of September 29, 2025. This non-set-aside competitive award was issued on September 8, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $147,872 delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Revlimid 10 mg capsules (28-count packages). This firm fixed-price delivery order, with an ultimate completion date of October 14, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999 through December 2026. The award was made through open competition with no...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Revlimid 15 mg capsules (100-count units) with a ceiling value of $53,251.31. This firm fixed price delivery order, with a completion date of September 4, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The contract was competitively...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ5ARDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $58,220.97 to AmerisourceBergen Drug Corp for REVLIMID 10 MG capsules (28-count units) on September 17, 2025, with a completion date of October 8, 2025. The contract employs firm fixed pricing and was awarded competitively without set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. The SPE2DX contract enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide. REVLIMID (lenalidomide) is a specialized pharmaceutical used in treating certain cancers and blood disorders, reflecting the contractor's role in providing both routine and specialty medications to federal military and veteran healthcare systems. As a child contract under the larger IDC vehicle, this delivery order demonstrates AmerisourceBergen's continued capability to meet federal procurement requirements through the flexible, competitive contracting mechanism that DLA Troop Support utilizes for medical supply chain management.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $58.2k | 9/17/25 |